| # | Filing Date | Period End Date | Type | Report Link | 
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	Maxim Group analyst Allen Klee downgrades Cryo-Cell International (AMEX:CCEL) from Buy to Hold.
																	
																	Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate ...
																	
																	Maxim Group analyst Allen Klee maintains Cryo-Cell International (AMEX:CCEL) with a Buy and lowers the price target from $9 ...
																	
																	Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate ...
																	
																	Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate ...